Driving Simulation to Assess Non-Sedative Effects of Tolperisone

NCT03353922 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurana Pharmaceuticals, Inc.

Collaborators